C07D215/02 - CPC Classification Index

ClassID:

94260 ⎘

C07D215/02 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom

Sub-classes:

C07D215/04 » with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms 97
C07D215/12 » with substituted hydrocarbon radicals attached to ring carbon atoms 447
C07D215/16 » with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms 17

Recent Application in this class:

20260107682

2026-04-16

COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY APPARATUS

20210395220

2021-12-23

QUINONE REDUCTASE 2 INHIBITOR COMPOUNDS AND USES THEREOF

20210017186

2021-01-21

Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same

20200383987

2020-12-10

Amide compound, and Pin1 inhibitor, therapeutic agent for inflammatory diseases and therapeutic agent for cancer that use the same

20200079781

2020-03-12

Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases

20190150439

2019-05-23

SOLUBLE LIQUID FORMULATIONS OF QUINCLORAC AMMONIUM SALTS

20190106513

2019-04-11

Transition metal compound and catalyst composition including the same

20180230102

2018-08-16

Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof

20170349674

2017-12-07

Transition metal compound and catalyst composition including the same

#10

20170305809

2017-10-26

Agent for introducing protecting group for hydroxy group and/or mercapto group

#11

20160280671

2016-09-29

Compositions for the treatment of hypertension and/or fibrosis

#12

20160060270

2016-03-03

Aryl-quinoline derivatives

#13

20150305336

2015-10-29

Soluble liquid formulations of quinclorac ammonium salts

#14

20140296212

2014-10-02

SUBSTITUTED PHENOXYPROPYLCYCLOAMINE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDS

#15

20130116234

2013-05-09

Aryl-quinoline derivatives

#16

20120238551

2012-09-20

Substituted phenoxypropylcycloamine derivatives as histamine-3 (H) receptor ligands

#17

20110178083

2011-07-21

PDE-10 inhibitors

#18

20100305326

2010-12-02

Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage

#19

20100188618

2010-07-29

Liquid-crystal display

#20

20080281105

2008-11-13

Novel Quinolinium Salts and Derivatives